Essex Investment Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q1 | – | Sell |
-4,284
| Closed | -$817K | – | 339 |
|
|
2015
Q4 | $817K | Hold |
4,284
| – | – | 0.13% | 172 |
|
|
2015
Q3 | $670K | Hold |
4,284
| – | – | 0.11% | 191 |
|
|
2015
Q2 | $774K | Sell |
4,284
-2,038
| -32% | -$368K | 0.12% | 187 |
|
|
2015
Q1 | $1.1M | Buy |
6,322
+2,740
| +76% | +$475K | 0.15% | 145 |
|
|
2014
Q4 | $663K | Sell |
3,582
-6
| -0.2% | -$1.11K | 0.1% | 195 |
|
|
2014
Q3 | $595K | Sell |
3,588
-15
| -0.4% | -$2.49K | 0.09% | 211 |
|
|
2014
Q2 | $563K | Sell |
3,603
-523
| -13% | -$81.7K | 0.08% | 237 |
|
|
2014
Q1 | $628K | Sell |
4,126
-1,511
| -27% | -$230K | 0.09% | 230 |
|
|
2013
Q4 | $749K | Buy |
5,637
+536
| +11% | +$71.2K | 0.11% | 229 |
|
|
2013
Q3 | $593K | Sell |
5,101
-2,036
| -29% | -$237K | 0.09% | 231 |
|
|
2013
Q2 | $658K | Buy |
+7,137
| New | +$658K | 0.12% | 199 |
|